The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
910526619 9105266 19 F 20130123 20160919 20130220 20160922 EXP US-GLAXOSMITHKLINE-A1011461A GLAXOSMITHKLINE 47.46 YR F Y 0.00000 20160922 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
910526619 9105266 1 PS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 23 NG/KG/MIN CONTINUOUSLYDOSE: 23.4 NG/KG/MIN, CONC: 30,000 NG/MLVIAL STRENGTH: 1.5 MG23.5 NG/K[...] U N307 20444 23 DF POWDER FOR INFUSION
910526619 9105266 2 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U N145 20444 POWDER FOR INFUSION
910526619 9105266 3 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U P057 20444 POWDER FOR INFUSION
910526619 9105266 4 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U P669 20444 POWDER FOR INFUSION
910526619 9105266 5 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S506 20444 POWDER FOR INFUSION
910526619 9105266 6 SS FLOLAN EPOPROSTENOL SODIUM 1 23.5 NG/KG/MIN CONTINUOUS U T366 20444 POWDER FOR INFUSION
910526619 9105266 7 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 24.7 NG/KG/MIN U T856 20444 24.7 DF POWDER FOR INFUSION
910526619 9105266 8 SS FLOLAN EPOPROSTENOL SODIUM 1 25 NG/KG/MIN U U052 20444 POWDER FOR INFUSION
910526619 9105266 9 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U 20444 POWDER FOR INFUSION
910526619 9105266 10 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U 20444 POWDER FOR INFUSION
910526619 9105266 11 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 25 DF, CO U V785 20444 25 DF POWDER FOR INFUSION
910526619 9105266 12 SS FLOLAN EPOPROSTENOL SODIUM 1 26 NG/KG/MIN CONTINUOUS; CONCENTRATION 30,000 NG/ML; PUMP RATE 80 ML/DAY; VIAL STRENGTH 1.5 MG/ML U W674 20444 POWDER FOR INFUSION
910526619 9105266 13 SS FLOLAN EPOPROSTENOL SODIUM 1 25.7 NG/KG/MIN CONTINUOUS; CONCENTRATION 30,000 NG/ML; PUMP RATE 79 ML/DAY; VIAL STRENGTH 1.5 MG/ML U Z880 20444 POWDER FOR INFUSION
910526619 9105266 14 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 19.5 DF, CO U Z880 20444 19.5 DF POWDER FOR INFUSION
910526619 9105266 15 SS FLOLAN EPOPROSTENOL SODIUM 1 4.9 NG/KG/MIN, CO U V925 20444 POWDER FOR INFUSION
910526619 9105266 16 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U CZ64454 0 SOLUTION FOR INJECTION
910526619 9105266 17 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U C764454 0 SOLUTION FOR INJECTION
910526619 9105266 18 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U C769109 0 SOLUTION FOR INJECTION
910526619 9105266 19 SS UPTRAVI SELEXIPAG 1 UNK Y 0
910526619 9105266 20 SS UPTRAVI SELEXIPAG 1 1400 UG, BID Y 0 1400 UG BID
910526619 9105266 21 SS UPTRAVI SELEXIPAG 1 1200 UG, BID Y 0 1200 UG BID
910526619 9105266 22 C TRACLEER BOSENTAN 1 Oral U 0 125 MG BID
910526619 9105266 23 C REVATIO SILDENAFIL CITRATE 1 Oral U 0 20 MG TID
910526619 9105266 24 C OPSUMIT MACITENTAN 1 0
910526619 9105266 25 C ADCIRCA TADALAFIL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
910526619 9105266 1 Pulmonary arterial hypertension
910526619 9105266 16 Pulmonary arterial hypertension
910526619 9105266 19 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
910526619 9105266 OT
910526619 9105266 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
910526619 9105266 Catheter site erythema
910526619 9105266 Catheter site infection
910526619 9105266 Catheter site pain
910526619 9105266 Catheter site swelling
910526619 9105266 Chest pain
910526619 9105266 Complication associated with device
910526619 9105266 Device leakage
910526619 9105266 Device related infection
910526619 9105266 Diarrhoea
910526619 9105266 Drug administration error
910526619 9105266 Dyspnoea
910526619 9105266 Feeling hot
910526619 9105266 Flushing
910526619 9105266 Food poisoning
910526619 9105266 Headache
910526619 9105266 Lower respiratory tract infection
910526619 9105266 Nausea
910526619 9105266 Pain
910526619 9105266 Palpitations
910526619 9105266 Pulmonary arterial hypertension
910526619 9105266 Pulmonary hypertension
910526619 9105266 Pyrexia
910526619 9105266 Skin infection
910526619 9105266 Upper respiratory tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
910526619 9105266 1 20110923 0
910526619 9105266 2 20110924 0
910526619 9105266 3 20110924 0
910526619 9105266 4 20110924 0
910526619 9105266 5 20110924 0
910526619 9105266 11 20110923 0
910526619 9105266 12 20110923 0
910526619 9105266 13 20110923 0
910526619 9105266 15 20110923 0
910526619 9105266 19 20160724 0